Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 868KRevenues
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Revenues Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - Revenues Historical data
| Date | Revenues |
|---|---|
| 6/30/2025 | $ 868K |
| 3/31/2025 | $ 1.85M |
| 12/31/2024 | $ 2.27M |
| 9/30/2024 | $ 2.28M |
| 6/30/2024 | $ 2.4M |
| 3/31/2024 | $ 1.76M |
| 12/31/2023 | $ 1.38M |
| 9/30/2023 | $ 1.24M |
| 6/30/2023 | $ 1.04M |
| 3/31/2023 | $ 581K |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) Revenues stands at $ 0.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average Revenues has been $ 808.7K.
- The median Revenues for BIOXCEL THERAPEUTICS INC during this period was $ 478K
- BIOXCEL THERAPEUTICS INC reached its highest Revenues over the past 5 years at $ 2.4M.
- The lowest Revenues recorded by BIOXCEL THERAPEUTICS INC in the same timeframe $ 0
BIOXCEL THERAPEUTICS INC's Revenues vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Revenues Benchmarks
Similar metrics to Revenues:
- Gross Margin - [Calculation] Gross margin, also called gross profit margin, represents the percentage of total revenue that the company retains after subtracting direct costs associated with producing the goods and services sold by the company [CoR]. Calculated by dividing gross profit [GP] by [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Cost of Revenue Margin - [Calculation] The Cost of Revenue [CoR] expressed as a percentage of [Revenue]. Also named Cost Revenue Ratio.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Revenues
[Income Statement] The sum of revenue generated from all sold goods and rendered services.BTAI - Revenues, Last 5 years
$ 0
Minimum
Sep 30, 2020
$ 2.4M
Maximum
Jun 30, 2024
$ 808.7K
Average
$ 478K
Median
Revenues Benchmark AnalysisMarket
The chart above depicts the distribution of Revenues for companies in the Total Stock Market. The average Revenues of the companies is $ 492.25M with a standard deviation of $ 677.8M.
The following table provides additional summary stats:
Revenues in the Market:
| filtered constituents | 3.23K |
|---|---|
| min | $ -131.22M |
| max | $ 2.77B |
| average | $ 492.25M |
| median | $ 157.9M |
| std | $ 677.8M |